rhinosinusitis%20-%20acute,%20bacterial
RHINOSINUSITIS - ACUTE, BACTERIAL
Acute bacterial rhinosinusitis is the mucosal inflammation of the nose and paransal sinuses caused by bacteria lasting >10 days for up to 4 weeks or symptoms worsening for 5-7 days within 10 days.
It is often preceded by a viral upper respiratory tract infection.
Signs and symptoms are nonspecific and typically difficult to differentiate from viral upper respiratory tract infection.
There is fever with nasal obstruction/congestion or anterior and/or posterior purulent drainage, with or without facial pressure/pain/fullness and reduction/loss of smell.
Streptococcus pneumoniae and unencapsulated strains of Haemophilus influenzae cause half of acute rhinosinusitis cases.

Diagnosis

  • Targeted history and physical exam are both beneficial and cost-effective during initial diagnosis
  • Acute viral, non-infectious and allergic rhinosinusitis must be ruled out to prevent inappropriate antibiotic treatment
  • Most guidelines diagnose acute bacterial rhinosinusitis (ABRS) based on clinical presentation
    • Gold standard for ABRS diagnosis is ≥104 colony-forming units (CFU)/mL of bacteria from paranasal sinus cavity
  • Diagnosis should be based on at least 3 of the following signs and symptoms:
    • Fever (>38°C)
    • Presence of severe local pain
    • With discolored discharge and purulent nasal secretion (nasal cavity)
    • Increased erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP)
    • Patients become worse at initial recovery or deterioration of signs and symptoms 
  • A presumptive diagnosis of ABRS should be made if patient presents with any of the following:
    • Persistent illness - presence of >10 days nasal discharge or daytime cough not relieved by medications
    • Worsening course - worsening of resolved previous or new onset nasal discharge, daytime cough, headache or pyrexia
    • Severe onset of the disease - fever ≥39°C with purulent nasal discharge or facial pain of ≥3 days duration

Evaluation

Severity of Acute Bacterial Rhinosinusitis (ABRS)

  • The severity of ABRS will reflect the need for antibiotic therapy
    • Mild ABRS may be managed with symptomatic therapy alone
    • Severe ABRS will need outright antibiotic management plus symptomatic medications
  • The severity assessment will also guide the analgesic therapy
  • Differences in severity do not necessarily imply antimicrobial resistance
  • The evaluation of disease severity will be dependent on clinical judgment
  • Evaluation of disease severity may be based on total severity visual analogue scale (VAS) score
    • Mild: VAS 0-3 cm
    • Moderate: VAS >3-7 cm
    • Severe: VAS >7-10 cm
  • Patients with moderate disease are more likely to need therapeutic intervention to achieve symptom resolution
    • Treatment failures will more likely be less tolerable in these patients
  • Severe or life-threatening illnesses should be referred to an emergency dept (ED) or otolaryngologist

Recent Antibiotic Use

  • Recent antibiotic use (within the last 4-6 weeks) is a major factor that is associated with increased risk of resistant pathogens

History

  • Persistent symptoms are moderately sensitive but are nonspecific predictors of acute bacterial rhinosinusitis (ABRS)
  • Pay particular attention on the speech which may indicate fullness of the sinuses
  • It is also important to include questions on allergic symptoms

Physical Examination

  • Examine the face for periorbital edema or other facial swelling
  • The nose should be examined for deviated septum, foreign bodies, nasal polyps and tumors
  • Perform anterior rhinoscopy to look for erythematous nasal mucosa, mucopurulent discharge, pus coming from the middle meatus
  • Examination of the ears may reveal concomitant otitis media
  • Percussion or direct pressure over the body of the frontal & maxillary sinuses may produce unilateral pain
  • Tapping of the maxillary teeth with a tongue depressor can be used to test for tenderness
  • Trans-illumination is of limited usefulness

Imaging

 Chest Radiography
  • Not required to diagnose acute rhinosinusitis (ARS) unless complications or alternative diagnoses are entertained 

Computed Tomography (CT) Scan

  • Gold standard in the evaluation of the paranasal sinuses
  • Used in quantifying the extent of inflammatory disease
    • This is based on the opacification of the paranasal sinuses
  • Indications for CT scan:
    • Presence of unilateral symptoms, blood-stained discharge, displacement of the eye and eye pain
    • Planning for a surgery
    • Failure of therapy (medical)
  • Contrast-enhanced CT scan rather than MRI is recommended for acute bacterial rhinosinusitis (ABRS) which is unresponsive to medical management, and those with suspected suppuration

 Magnetic Resonance Imaging (MRI)

  • MRI with contrast of the paranasal sinuses may be considered for pediatric and adult patients suspected of orbital or central nervous system (CNS) involvement

Laboratory Tests

Culture and Susceptibility Test

  • Documents bacterial infection and resistance pattern
  • Cultures from direct aspiration of sinus are recommended in patients who have failed empiric therapy
    • Alternative could be culture from middle meatus via endoscopy
    • Nasopharyngeal swab culture is not recommended

Anterior Rhinoscopy

  • Used for clinical assessment of patients suspected with ARS (primary care setting)
  • May reveal polyps, inflammation, mucosal edema, purulent discharges and other anatomical abnormalities

Nasal Endoscopy

  • Rigid endoscopy is preferred because it provides clear images and is more comfortable for patients
  • Facilitates culture and tissue sampling
  • Enables endoscopists to perform nasal toileting

Other Procedures
Maxillary Sinus Taps (MST) for Sinus Puncture and Aspiration

  • The gold standard in determining the etiology of ABRS
    • Due to its invasive nature, this procedure is rarely performed

Endoscopically-Directed Middle Meatal Culture (EDMMC)

  • A less invasive procedure than MST
  • Has comparable performance with a sinus CT scan
  • May also be used in obtaining the specimen for culture and susceptibility tests for unresolved cases of bacterial rhinosinusitis
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
22 May 2017
Chronic obstructive pulmonary disease (COPD) is currently the 10th commonest cause of death in Singapore, with a disease burden of 5.9 percent according to a 2015 population-based survey (EPIC-Asia survey) in Singapore. Pearl Toh spoke with Dr Augustine Tee, chief and senior consultant of the Department of Respiratory and Critical Care Medicine at Changi General Hospital (CGH) in Singapore, on how COPD is often underdetected in the primary care population as symptoms are not specific and diagnosis requires a combination of clinical risk factors, symptoms and spirometry testing.
15 Aug 2017
New drug applications approved by US FDA as of 1 - 15 August 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
04 Aug 2017
Chronic obstructive pulmonary disease (COPD) is the fourth cause of global mortality, with experts predicting a potential future rise in the prevalence rates of COPD. 
11 May 2016

In conjunction with World Asthma Day which falls on 3rd May 2016, MIMS Doctor speaks to a renowned respiratory medicine specialist, Dato' Dr. Hj Abdul Razak Abdul Muttalif, regarding the chronic airway disease.